CTH Share Price

Open 1.24 Change Price %
High 1.24 1 Day 0.04 3.33
Low 1.17 1 Week 0.00 0.00
Close 1.24 1 Month 0.00 0.00
Volume 98553 1 Year 0.00 0.00
52 Week High 0.50
52 Week Low 0.05
CTH Important Levels
Resistance 2 1.30
Resistance 1 1.28
Pivot 1.22
Support 1 1.20
Support 2 1.18
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
CBE 0.02 100.00%
CBE 0.02 100.00%
CBE 0.02 100.00%
NUK 0.02 100.00%
BVQ 0.02 100.00%
DDX 0.50 100.00%
DYG 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
RDM 0.21 90.91%
More..
CVE Canada Top Losers Stocks
ARH 0.00 -100.00%
ARH 0.00 -100.00%
MLR 0.02 -50.00%
MLR 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Cynapsus Therapeutics, Inc. (CVE: CTH)

CTH Technical Analysis 5
As on 27th Nov 2014 CTH Share Price closed @ 1.24 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.76 & Strong Buy for SHORT-TERM with Stoploss of 0.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
CTH Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
CTH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.cynapsus.ca
CTH Address
CTH
828 Richmond Street West
Toronto, ON M6J 1C9
Canada
CTH Latest News
Interactive Technical Analysis Chart Cynapsus Therapeutics, Inc. ( CTH CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cynapsus Therapeutics, Inc.
CTH Business Profile
Cynapsus Therapeutics Inc., a specialty pharmaceutical company, is engaged in developing an enhanced dosing formulation of an approved drug used to treat the symptoms of Parkinson’s disease. Its product candidate includes APL-130277, an easy-to-administer and fast-acting reformulation of apomorphine, which is used to rescue patients from off episodes. The company was formerly known as Cannasat Therapeutics Inc. and changed its name to Cynapsus Therapeutics Inc. in April 2010. Cynapsus Therapeutics Inc. is headquartered in Toronto, Canada.